Prana recruiting for Alzheimer's drug trial

12/15/2011 | MarketWire

Prana Biotechnology said it has started screening patient participants for a Phase II imaging trial of its experimental Alzheimer's disease drug PBT2. The trial will use PiB-PET imaging and blood tests to determine the effects of the drug.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT